Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
2
×
clinical trials
eli lilly
fda
genentech
2
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avapritinib
avexis
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
cstone pharmaceuticals
dana hilt
daprodustat
david chacko
What
fda
regulatory
2
×
approval
august
bio
biotech
blueprint
busy
cancer
candidate
currently
days
decisions
devices
drug
drugs
legacy
marketing
medicines
muscle
news
nods
opioid
pact
past
ret
review
roche
roundup
sarepta’s
seven
shkreli’s
slow
stumble
suits
team
tends
wins
won
Language
unset
2
×
Current search:
genentech
×
regulatory
×
" boston blog main "
×
unset
×
" boston top stories "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More